Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Ferrer selects new development candidate for the treatment of hypertension

Sep. 28, 2000

Trial of novel restenosis treatment AGI-1067 set to begin

Sep. 28, 2000

Simdax approved in Sweden for severe heart failure

Sep. 28, 2000

Plant-derived lignan demonstrates inotropic and antidiuretic effects

Sep. 27, 2000

Japanese approval granted for Diovan, a new antihypertensive agent

Sep. 26, 2000

Consensus on Statins -- International Task Force Webcast now available on demand

Sep. 26, 2000

Lisinopril found to regress myocardial fibrosis in hypertensive patients

Sep. 26, 2000

Water-soluble inhibitors of Lp-PLA2: a novel approach to antiatherosclerotic therapy

Sep. 25, 2000

Novel conjugated renin inhibitors with prolonged in vivo activity designed at ConjuChem

Sep. 21, 2000

SB and Symphar join efforts to discover Lp(a)-lowering agents for atherosclerosis

Sep. 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...